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Background: Therapeutic hypothermia (TH) is a standard strategy to reduce brain damage in post-cardiac arrest
syndrome (PCAS) patients. However, it is unknown whether the target temperature should be adjusted for PCAS
patients in different states.
Methods: Participants in the J-PULSE-Hypo study database were divided into lower (32.0–33.5 °C; Group L) or
moderate (34.0–35.0 °C; Group M) temperature groups. Primary outcome was a favourable neurological outcome
(proportion of patients with a Glasgow-Pittsburgh Cerebral Performance Category [CPC] of 1–2 on day 30). We
compared between the two groups and in subgroups of patients divided by age and resuscitation interval (interval
from collapse to return of spontaneous circulation) by propensity score (PS) analysis.
Results: Overall, 467 participants were analysed. The proportions of patients with favourable neurological outcomes
were as follows (Group L vs. Group M) (OR; Odds ratio): all patients, 64 % (n = 42) vs. 55 % ((n = 424) (PS; OR 1.381
(0.596–3.197)), P = 0.452) and resuscitation interval≤ 30 min, 88 % (n = 24) vs. 64 % ((n = 281) (PS; OR 7.438
(1.769–31.272)), P = 0.007).
Conclusions: PCAS patients with a resuscitation interval of <30 min may be candidates for TH with a target
temperature of <34 °C.
Trial registration: University Hospital Medical Information Network (UMIN) Clinical Trials Registry UMIN000001935;
available at: https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function=brows&action=brows&type=summary&
recptno=R000002348&language=J.
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The efficacy of therapeutic hypothermia (TH) in post-
cardiac arrest syndrome (PCAS) patients was demon-
strated by two, randomised controlled studies [1, 2].
Current guidelines for resuscitation now recommend
TH of 32–34 °C for 12–24 h in PCAS patients. How-
ever, a recent randomised controlled trial, the target
temperature management (TTM) study [3], did not
show any benefit of TH (33 °C) for PCAS patients when
comparing TH (33 °C) and controlled normothermia
(36 °C). Therefore, there is still no clear evidence to
show whether lower temperature treatment or anti-
fever treatment should be considered for managing
PCAS patients. Despite the limited clinical evidence,
recent animal studies have shown beneficial effects of
TH on neurological outcomes [4–6]. This raises the
question of what causes the differences in the neuro-
logical outcomes between clinical and animal studies.
Therefore, we hypothesised that there are some sub-
groups of patients in clinical settings who may show
the greatest efficacy of lower target temperature TH.
The J-PULSE-Hypo study registry is a Japanese pro-
spective cohort observational study of TH in PCAS pa-
tients. A total of 14 medical centres participated in this
registry, which was originally conducted between Janu-
ary 2005 and 2009, and was then extended to March
2013 [7]. In the present study, we performed analyses
of the J-PULSE-Hypo registry database to address our
objective, which was to identify subgroups of patients




The present study used the J-PULSE-Hypo registry data-
base, a prospective cohort database of PCAS patients
who received TH at 14 Japanese hospitals. Patients were
registered between January 2005 and December 2012.
The study was conducted in accordance with the ethical
guidelines for epidemiological studies and was approved
by the ethics committee of the National Cerebral and
Cardiovascular Center. Ethical review boards at all 14
participating centres approved the study protocol.
Patients
Patients satisfying the following criteria were eligible for
registration: (1) all patients who received TH at any of
the 14 participating facilities with successful return of
spontaneous circulation (ROSC) after out-of-hospital
cardiac arrest; (2) patients aged ≥18 years; (3) stable
hemodynamics after ROSC, including stabilisation by
drugs or assisted circulation, such as intra-aortic balloon
pumping or percutaneous cardiopulmonary support; (4)
persistent coma (Japan coma scale score of 200 or 300,or Glasgow coma scale score of 3–5) after ROSC; and
(5) presumed cardiac aetiology of cardiac arrest accord-
ing to the Utstein guidelines [8]. Patients were excluded
for the following reasons: pregnancy, aortic dissection,
pulmonary embolism, drug addiction, and poor daily
activity before the onset of cardiac arrest.
Treatment
TH was performed with sedation and analgesia accord-
ing to the hospital’s established procedures. In some
cases, ice-cold intravenous fluid was administered over
30–60 min to initiate hypothermia. Hypothermia was ini-
tiated and/or maintained by (1) surface cooling with a
cooling blanket (Blanketrol II; CSZ Medical, Cincinnati,
OH, USA) or a cooling device with self-adhesive,
hydrogel-coated pads (Arctic Sun; Medivance, Louisville,
KY, USA), or by (2) blood cooling with an extracorpor-
eal direct blood cooling device (KTEK-III, Kawasumi,
Tokyo, Japan) or an endovascular cooling device (Cool-
Gard 3000; Alsius, Irvine, CA, USA). Mild hypothermia
(32–35 °C) was maintained for 24–72 h. Rewarming
was conducted slowly and gradually over at least 24–
72 h. The hypothermia protocol was conducted accord-
ing to each institution’s protocols.
Study outcomes and statistical analysis
The patients were divided into two groups according to
the target temperature as either <34 °C (32.0–33.5 °C;
low temperature, Group L) or ≥34 °C (34.0–35.0 °C;
moderate temperature, Group M).
The patient’s neurological outcome was assessed using
the Glasgow-Pittsburgh Cerebral Performance Category
(CPC), which included the following five categories:
CPC 1 (good recovery), CPC 2 (moderate disability),
CPC 3 (severe disability), CPC 4 (vegetative state), and
CPC 5 (death) [9]. In the present study, a favourable pri-
mary outcome was defined as CPC 1–2 on day 30.
About cooling method, the duration of time at the tar-
get temperature is the duration (h) of keeping the target
temperature; rewarming time is the duration (days) with
which rewarming starts to reach 36.0 °C; Over-cooling is
defined as less than 0.5 °C from target temperature.
The proportion of patients with a favourable neuro-
logical outcome was compared between the two groups
for all patients and for specified subgroups of patients
using univariate and multivariate analyses with propen-
sity score analysis. In the present study, age and resusci-
tation interval were eligible factors for the subgroup,
which were thought of as global factors having influence
for the outcome; 60 years old and 30 min were treated
as cut-off values from the median of the previous cohort
study [10]. The following subgroups of patients were
analysed: age ≤60 vs. >60 years and resuscitation interval
(interval from collapse to ROSC) of ≤30 vs. >30 min.
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Whitney U test and Fisher’s exact test as appropriate.
Propensity score analysis was performed by taking into
account age, sex (male), bystander cardiopulmonary re-
suscitation (CPR), cardiogenic cardiac arrest, and resus-
citation interval using the inverse probability of the
treatment-weighting (IPTW) method. All statistical ana-
lyses were considered significant at P < 0.05.
Statistical analyses were performed using SPSS soft-
ware version 16.0 (IBM, Armonk, NY, USA) for all ana-
lyses, except for propensity score analysis, which was
conducted using R software version 3.1.2 (GNU general
public licence).
Results
The registry included 467 patients, but the target
temperature was not stated for ten patients. The char-
acteristics of the analysed patients are summarised in
Table 1. Age, target temperature, maintenance of the
target temperature, and the rewarming process were
significantly different between Groups L and M.
Table 2 compares the proportions of patients with a
favourable neurological outcome between Groups L and
M for all patients and in each subgroup. The proportion




Age (years) 52 (44–6
Male (%) 37 (88 %
Bystander CPR (%) 18 (43 %
Witness (%) 27/34 (7
Cardiogenic cardiac arrest (%) 41 (98 %
VF/VT (%) 35/42 (8
Target temperature (°C) 33.0 (33
Over-cooling (%) 15/42 (3
Interval from collapse to ROSC (min) 24 (15–4
Interval from ROSC to target temperature (min) 180 (105
Duration of time at the target temperature (h) 34 (24–5
Rewarming time (days) 3 (2–4)
Cooling method
Initial infusion of cold fluid 27/42 (6
Surface cooling 27/42 (6
Device used
Percutaneous cardiopulmonary support 6/30 (20
CPC 1–2 on day 30 27 (64 %
Values are presented as the n (%) or median (interquartile range)
CPR cardiopulmonary resuscitation, VF ventricular fibrillation, VT, ventricular tachyca
performance categorydifferent between Groups L and M in the subgroup of
patients with a resuscitation interval of ≤30 min (88 %
(n = 24) vs. 64 % (n = 281) odds ratio (OR) 3.867 (1.126–
13.286), P = 0.024) [OR; odds ratio (95 % confidence
interval)].
Table 3 shows the characteristics of patients in Groups
L and M in the subgroup of patients with a resuscitation
interval of ≤30 min. The age in the background showed
significant difference in this subgroup (50 vs. 62 years
old).
Table 4 shows the results of the propensity score ana-
lysis comparing the proportion of patients with a
favourable neurological outcome between Groups L and
M. This analyses shows that the proportion of patients
with a favourable neurological outcome was significantly
different between Groups L and M in the subgroup of
patients with a resuscitation interval of ≤30 min (OR;
7.438 (1.769–31.272), P = 0.007).
Table 5 compares the proportion of patients with a
favourable neurological outcome in the subgroup of pa-
tients with a resuscitation interval of ≤30 min. As shown
in this table, the proportion of patients was significantly
different between Groups L and M for the overall
subgroup and for patients with ventricular fibrillation/
ventricular tachycardia (VF/VT) (88 % (n = 24) vs. 64 %Group M P value
.5 °C) (34.0–35.0 °C)
n = 425
1) 61 (53–69) <0.001
) 349 (82 %) 0.399
) 225 (53 %) 0.257
9 %) 298/373 (80 %) 1.000
) 398 (94 %) 0.497
3 %) 286/419 (68 %) 0.052
.0–33.0) 34.0 (34.0–34.0) <0.001
6 %) 86/404 (21 %) 0.051
1) 21 (13–34) 0.154
–290) 170 (74–335) 0.657
0) 25 (24–38) 0.004
2 (1–3) <0.001
4 %) 229/425 (54 %) 0.255
4 %) 197/416 (47 %) 0.051
%) 84/325 (26 %) 0.661
) 232 (55 %) 0.258
rdia, ROSC return of spontaneous circulation, CPC cerebral
Table 2 Proportions of patients with favourable neurological outcomes according to the target temperature of therapeutic hypothermia
Variable Target temperature n CPC 1–2 on day 30 OR (95 % CI) P value
All patients <34 °C 42 27 (64 %) 1.490 (0.770–2.881) 0.258
≥34 °C 424 232 (55 %)
Age
≤60 years <34 °C 30 21 (70 %) 1.167 (0.507–2.685) 0.836
≥34 °C 204 136 (67 %)
>60 years <34 °C 12 6 (50 %) 1.292 (0.404–4.131) 0.769
≥34 °C 220 96 (44 %)
Resuscitation interval
≤30 min <34 °C 24 21 (88 %) 3.867 (1.126–13.286) 0.024
≥34 °C 281 181 (64 %)
>30 min <34 °C 14 3 (21 %) 0.678 (0.178–2.586) 0.756
≥34 °C 115 33 (29 %)
Values are presented as the n (%)
CPC cerebral performance category, OR odds ratio, CI confidence interval
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(n = 21) vs. 71 % (n = 185) OR; 8.244 (1.079–62.975), P =
0.017, respectively).
Table 6 shows the results of the propensity score ana-
lysis to compare the proportion of patients with a
favourable neurological outcome between Groups L and
M in a subgroup of patients with an interval of 30 min
from collapse to ROSC and VF/VT. The difference in
the proportion of patients with a favourable neurological
outcome was statistically significant between Groups L
and M in this subgroup of patients (OR; 19.43 (2.39–




Age (years) 50 (38–
Male (%) 19 (79 %
Bystander CPR (%) 9 (38 %
Witness (%) 17/21 (8
Cardiogenic cardiac arrest (%) 23 (96 %
VF/VT (%) 21/24 (8
Target temperature (°C) 33.0 (32
Over-cooling (%) 7/24 (29
Interval from collapse to ROSC (min) 17 (11–
Interval from ROSC to target temperature (min) 194 (16
Duration of time at the target temperature (h) 34 (24–
Rewarming time (days) 3 (2–4)
CPC 1-2 on day 30 (%) 21 (88 %
Values are presented as the n (%) or median (interquartile range)
CPR cardiopulmonary resuscitation, VF ventricular fibrillation, VT ventricular tachyca
performance categoryDiscussion
In the present study, TH with a lower target temperature
of 32.0–33.5 °C (i.e. Group L) significantly improved the
proportion of patients with favourable neurological out-
comes in the subgroup of patients with a resuscitation
interval of ≤30 min, as compared with TH with a higher
target temperature of 34.0–35.0 °C (i.e. Group M)
(Table 2). However, it must be acknowledged that with
the background characteristics of Groups L and M, the
age in the background showed significant difference in
this subgroup (50 vs. 62 years old) (Table 3). Therefore,
propensity score analysis with the IPTW method was0 min
Group M P
value.5 °C) (34.0–35.0 °C)
n = 281
57) 62 (53–69) <0.001
) 228 (81 %) 0.789
) 146 (52 %) 0.205
1 %) 205/256 (80 %)
) 263 (70 %) 1.000
8 %) 185/277 (67 %)
.0–33.0) 34.0 (34.0–34.0) <0.001
%) 54/270 (20 %)
23) 15 (10–22) 0.469
5–324) 180 (95–360) 0.460
49) 24 (24–38) 0.013
2 (1–3) <0.001
) 181 (64 %) 0.024
rdia, ROSC return of spontaneous circulation, CPC cerebral
Table 4 Comparison of the proportion of patients with a favourable neurological outcome between the two target temperature
groups using propensity score analysis with the inverse probability of the treatment-weighting method
Variable Target temperature OR (95 % CI) P value
All patients <34 °C (vs. ≥34 °C) 1.381 (0.596–3.197) 0.452
Age
≤60 years <34 °C (vs. ≥34 °C) 0.779 (0.297–2.147) 0.657
>60 years <34 °C (vs. ≥34 °C) 3.812 (0.945–15.367) 0.061
Resuscitation interval
≤30 min <34 °C (vs. ≥34 °C) 7.438 (1.769–31.272) 0.007
>30 min <34 °C (vs. ≥34 °C) 0.583 (0.145–2.344) 0.449
The propensity score analysis incorporated the following variables: age, sex (male), bystander cardiopulmonary resuscitation, cardiogenic cardiac arrest, and
resuscitation interval
OR odds ratio, CI confidence interval
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outcome between Groups L and M in this subgroup of
patients (Table 4).
We also found a significant difference in the VF/VT
ratio between Group L and M (88 % vs. 67 %) in patients
with a resuscitation interval of ≤30 min. Therefore, to
confirm that the effectiveness of lower target temperature
TH was independent of the VF/VT ratio, we compared
the outcomes between VF/VT and non-VF/VT cases,
because VF/VT cases tend to have better outcomes than
non-VF/VT cases [10]. In VF/VT cases, we found that the
lower target temperature TH conferred better neurological
outcomes, but there was no difference between the two
groups of patients in non-VF/VT cases (Tables 5 and 6).
The TTM study included two groups of patients with
target temperatures of 33 and 36 °C. The characteristics
of both groups were similar in terms of their mean age
(33 vs. 36 °C; 64 vs. 64 years old, respectively), propor-
tion of males (83 vs. 79 %, respectively), proportion of
patients receiving bystander CPR (73 vs. 73 %, respect-
ively), proportion of patients with VF/VT (73 vs. 73 %,
respectively), and mean interval from collapse to ROSC
(25 vs. 25 min, respectively) [3]. Comparing the TTM study
and our study, it is apparent that our study population wasTable 5 Proportions of patients with favourable neurological outcom
hypothermia in patients with a resuscitation interval of ≤30 min
Variable Target temperature n
Resuscitation interval ≤30 min <34 °C 24
≥34 °C 281
<34 °C
VF/VT ≥34 °C 21
<34 °C 185
Non-VF/VT ≥34 °C 3
92
Values are presented as the n (%)
CPC cerebral performance category, VF ventricular fibrillation, VT ventricular tachycayounger, and bystander CPR was less frequent, but the
resuscitation interval was similar.
There were some differences between our study and
the TTM study, including shorter time to reach the
target temperature (our study vs. TTM study; 180 vs.
about 480 min), longer time at the target temperature
(34 vs. about 20 h), and longer rewarming period (3 days
vs. 9 h). Several animal studies have demonstrated po-
tential beneficial outcomes of rapid cooling [11–13];
prolonged TH may reduce secondary brain damage [14];
and slow rewarming may attenuate traumatic brain in-
jury [15–18]. Therefore, it seems that these TH methods
improved the neurological outcomes of PCAS patients.
Therefore, there might be a possibility that the funda-
mental cooling method (prolonged TH and long
rewarming period) had an advantage for outcome. Actu-
ally, the favourable outcome of the present study (Group
L; 64 % and Group M; 55 %) could be superior to the
outcome of TTM study (33 °C group; 46 % and 36 °C
group; 48 %). This topic should be discussed in a further
study.
Based on the results of animal studies, it is thought
that lower target temperature TH could improve the
neurological outcomes compared with higher targetes according to the target temperature of therapeutic
CPC 1–2 on day 30 OR (95 % CI) P value
21 (88 %) 3.867 (1.126–13.286) 0.024
181 (64 %)
20 (95 %) 8.244 (1.079–62.975) 0.017
131 (71 %)
1 (33 %) 0.479 (0.042–5.465) 0.617
47 (51 %)
rdia, OR odds ratio, CI confidence interval
Table 6 Comparison of the proportion of patients with a
favourable neurological outcome between the two target
temperature groups using propensity score analysis with the
inverse probability of the following treatment-weighting
method: patients with a resuscitation interval of ≤30 min and
ventricular fibrillation/ventricular tachycardia
Variable Target temperature OR (95 % CI) P value
VF/VT <34 °C (vs. ≥34 °C) 19.43 (2.39–158.04) 0.006
The propensity score analysis incorporated the following variables: age, sex
(male), bystander CPR, and resuscitation interval
OR odds ratio, CI confidence interval
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shown similar effects of lower target temperature TH in
humans. In the present study, we found that patients with
a resuscitation interval of ≤30 min had better outcomes
following lower target temperature TH, and this shorter
resuscitation interval might mimic the design of animal
studies. Irrespective of the reason, it seems that lower
target temperature TH might be advantageous in pa-
tients with a shorter resuscitation interval.
Extracorporeal cooling is currently applied in the clinical
setting, and it is vital that the target temperature is
reached within 20 min after starting cooling [19]. A recent
clinical study showed that a combination of TH with rapid
cooling and a cardiopulmonary support device improved
the neurological outcomes compared with conventional
methods, when performed about 60 min after VF/VT car-
diac arrest. [20] However, it is not clear whether rapid
cooling and/or the support device contributed to the im-
proved outcomes. It is possible that quicker cooling could
improve the outcome and expand the induction period of
TH. In the present study, in which induction cooling was
achieved within 180 min, a significant difference between
the two target temperatures was only noted for patients
with a resuscitation interval of ≤30 min.
This study has some limitations to mention. First, we
performed subgroup analyses of an observational study.
Therefore, the results should be confirmed in future stud-
ies. Second, several cooling methods were used, but any
advantages of the cooling methods could not be shown in
this study. Third, the effects of the cooling protocol were
not analysed in sufficient detail because of differences in
the maintenance and rewarming processes between the
two groups of patients. Fourth, neurological outcome was
assessed on day 30, which might not be enough observa-
tion periods.
Conclusions
Although lower target temperature TH for PCAS pa-
tients has not been established, including indications,
methods, and procedures, the present results might indi-
cate that lower target temperature TH could be candi-
date for patients with a resuscitation interval of ≤30 min.
We conclude that these results warrant further studiesexamining the effects of lower target temperature TH in
PCAS patients.
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